Skip to main content
main-content
Top

12-11-2019 | Ankylosing spondylitis | Video | Article

ACR/ARP 2019

Researcher comment: The SELECT-AXIS 1 trial

Désirée van der Heijde discusses the results of SELECT-AXIS 1, a phase II/III trial demonstrating that upadacitinib may be a promising treatment option for ankylosing spondylitis (2:27).

Transcript

Back to the ACR/ARP 2019 conference hub

Image Credits